Treatment Overview
Endoscopic Cyclophotocoagulation (ECP) in Korea is a highly precise Minimally Invasive Glaucoma Surgery (MIGS) procedure that lowers intraocular pressure (IOP) by directly treating the ciliary processes responsible for aqueous humor production. Unlike traditional transscleral cyclophotocoagulation, ECP uses an endoscope-equipped laser probe inserted through a micro-incision to deliver energy with direct visualization—greatly enhancing safety, accuracy, and predictability.
Korean ophthalmology centers perform ECP using micro-incisional phaco-compatible entry systems, 3D endoscopic visualization, diode laser modulation, OCT-guided targeting, and AI-driven energy mapping. This transforms ECP into a controlled, tissue-sparing procedure ideal for both standalone glaucoma surgery and combined cataract operations.
Purpose & Benefits
Purpose
- Reduce aqueous humor production by ablating or shrinking targeted ciliary processes.
- Achieve stable intraocular pressure reduction with minimal tissue disruption.
- Provide a safe, controlled alternative to external cyclophotocoagulation.
- Reduce the need for long-term glaucoma medication.
Benefits
- Direct Visualization: Surgeons can see the ciliary processes in real time, increasing safety.
- Controlled Laser Application: Minimizes risk of overtreatment or tissue damage.
- Compatible With Cataract Surgery: Often combined with phacoemulsification for dual benefits.
- Effective IOP Reduction: Suitable for mild, moderate, and selected advanced stages.
- Minimally Invasive: No external incisions beyond the standard micro-access port.
- Reduced Medication Burden: Many patients reduce or eliminate glaucoma drops.
- Repeatable: Can be performed again if additional IOP control is needed.
Ideal Candidates
Endoscopic Cyclophotocoagulation in Korea is ideal for:
- Patients with mild to moderate open-angle glaucoma.
- Individuals undergoing combined cataract + MIGS surgery.
- Patients seeking a tissue-sparing, minimally invasive alternative to filtering surgeries.
- Individuals who are intolerant of medications or require improved IOP control.
- Patients needing a targeted approach to reduce aqueous production.
- Selected patients with ocular hypertension or early glaucoma progression.
Possible Risks & Complications
ECP has an excellent safety profile due to direct visualization, but mild effects may occur:
- Temporary inflammation or redness
- Short-lived blurred vision
- Mild eye discomfort
- Transient IOP fluctuations
- Rare localized swelling
Korean ophthalmologists minimize risks through AI-calibrated energy delivery, intraoperative imaging guidance, and precise endoscopic targeting.
Surgical Techniques
AI-Based Treatment Planning
Analyzes ciliary body structure, glaucoma severity, and optimal laser dose.
Micro-Incision Access
A 2.0–2.2 mm incision provides entry for the endoscope and laser probe.
Endoscopic Visualization
A combined video camera, light source, and laser allows real-time imaging of ciliary processes.
Laser Ablation or Shrinkage
Laser energy is applied to each ciliary process to reduce aqueous production safely.
360º or Sector-Based Treatment
Depending on IOP goals, surgeons may treat 180º, 270º, or the full 360º.
OCT-Guided Verification
Ensures optimal ciliary body exposure and safe laser application.
Treatment Process in Korea
Step-by-Step Workflow
Step 1 – Comprehensive Glaucoma Assessment
Includes OCT imaging, visual field testing, IOP measurement, and AI-based energy mapping.
Step 2 – Surgical Planning
Surgeons define treatment extent (partial vs. full 360º) based on disease severity.
Step 3 – Micro-Incision & Endoscope Entry
A small corneal incision is made; the endoscope is advanced behind the iris for visualization.
Step 4 – Laser Application
Ciliary processes are precisely treated using diode laser energy.
Step 5 – Postoperative Monitoring
Ongoing assessments ensure inflammation control and stable IOP reduction.
Treatment Duration: 10–20 minutes per eye
Setting: Outpatient or combined with cataract surgery
Recovery & After-Care
After-Care Guidelines
- Use anti-inflammatory and antibiotic drops for 1–2 weeks.
- Avoid strenuous activities, heavy lifting, and eye rubbing for several days.
- Wear protective eyewear outdoors during recovery.
- Continue or taper glaucoma medications as advised.
- Attend follow-up visits at Day 1, Week 1, and Month 1.
Recovery Timeline
Days 1–3: Mild irritation or blurred vision.
Week 1: Decreased inflammation; gradual IOP reduction begins.
Weeks 2–4: Stabilized vision and consistent IOP control.
1–3 Months: Long-term stabilization with reduced medication needs.
Results & Longevity
Expected Results
- Effective reduction of aqueous humor production.
- Stable, long-term IOP lowering.
- Decreased medication requirements.
- Predictable postoperative course due to direct visualization.
Longevity
- Results typically last for years, depending on glaucoma type and severity.
- ECP can be repeated safely if IOP begins to rise.
- Korean clinics enhance longevity through AI-driven dosage and careful long-term monitoring.
Why Korea Is a Top Destination
- High-Precision MIGS Expertise: Korean surgeons excel in endoscopic-based glaucoma procedures.
- Advanced Imaging Integration: Real-time endoscopic visualization combined with OCT guidance.
- AI-Driven Energy Calibration: Personalized treatment intensity for optimal results.
- Minimally Invasive Approach: Less trauma, faster healing, and improved comfort.
- Outstanding Safety & Success Rates: Consistently positive outcomes with low complication rates.
Unique Korean Innovations
- AI-enhanced energy mapping for customized ciliary treatment.
- 3D endoscopic visualization for maximum accuracy.
- Hybrid MIGS integration (ECP + Canaloplasty or Goniotomy).
- Real-time thermal safety control.
- Long-term monitoring programs with deep-learning glaucoma progression analysis.
These innovations make Endoscopic Cyclophotocoagulation in Korea one of the most precise, safe, and effective MIGS options for lowering IOP in glaucoma patients.
Cost Range (Indicative Estimate)
| Treatment Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard ECP Procedure | ₩1,800,000 – ₩2,800,000 | ~$1,350 – $2,100 | Endoscopic treatment with standard follow-up |
| Premium OCT-Guided ECP Package | ₩3,000,000 – ₩4,500,000 | ~$2,200 – $3,400 | AI planning, OCT assistance, extended monitoring |
| Hybrid MIGS ECP Program | ₩4,800,000 – ₩6,500,000+ | ~$3,600 – $4,900+ | Combined ECP + other MIGS for advanced IOP control |
Pricing varies depending on clinic, technology platform, and surgeon expertise.
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul): Specializes in advanced endoscopic MIGS such as ECP.
- Dream Eye Center (Seoul): Known for OCT-assisted visualization and customized laser therapy.
- BGN Eye Clinic (Seoul & Busan): Experts in hybrid ECP and combined cataract-glaucoma surgery.
- Glory Seoul Eye Clinic: Focuses on real-time ciliary targeting and inflammation control.
- K-Cure Vision Center (Gangnam): Leaders in AI-enhanced laser planning and precision MIGS.
